New Joint and Spine Clinic to Open on Lutheran Home Campus in Arlington Heights
Led by esteemed physicians Dr. Sajjad Murtaza and Dr. Akash Jindal, the clinic will serve the residents of Lutheran Home as well as the broader Arlington Heights community. Dr. Murtaza, a double board-certified specialist in sports medicine and interventional pain, has a long-standing presence in the northwest Chicago area and helped establish the Spine Center at Northwest Community Hospital.
Lutheran Home's many services help residents with a full spectrum of care and services, including its MyRehab, which offers outpatient and short-term rehabilitation therapy. The new Joint and Spine clinic will work cooperatively with MyRehab, providing treatments in a light-filled environment that features private suites, a state-of-the-art therapy gym, atrium spaces, spacious living rooms and bistro-style dining.
'This clinic is designed to optimize therapy and work closely with the MyRehab physical therapy suite to provide customized, post-treatment plans,' said Dr. Murtaza. 'We want to educate the community on pain management options and introduce them to treatments that can significantly improve their quality of life.'
The Joint and Spine Clinic will focus on identifying pain generators and addressing the root causes of pain through non-surgical, interventional medicine. The clinic will not offer opioids or chiropractic care but will instead provide advanced procedures such as diagnostic injections, EMG imaging and therapeutic interventions for spine and joint conditions. While imaging such as MRIs will be conducted at local hospitals, many treatments, including injections, will be available on-site.
'This new clinic is a perfect addition to our campus, offering residents and community members convenient access to outstanding doctors and cutting-edge treatments,' said Jennifer Darnell, VP of Sales & Marketing at Lutheran Life Communities. 'We are happy to offer these innovative treatments to enhance the health and wellness of our residents, and having these services available on-site means they can conveniently receive expert care.'
SERVICES OFFERED AT THE JOINT AND SPINE CLINIC:
Currently, 40% of patients at Dr. Murtaza's other clinics are seniors who receive physical medicine and rehabilitation. With a majority of residents at Lutheran Home experiencing at least one spine or joint issue, this clinic aims to meet a significant need. By bringing treatment directly to the Lutheran Home campus, residents and community members will benefit from a local, convenient resource.
'We have found that most patients are not even aware or have never been educated on what treatments are available for their joint and spine pain and the great outcomes they can have,' said Dr. Murtaza. 'We are looking forward to offering relief to Lutheran Home residents and to the community.'
The clinic will begin with limited hours, and accepts most private insurance plans and Medicare. Patients will also have access to convenient communication methods, including text-based appointment updates and a secure HIPAA-compliant system for submitting insurance information.
Appointments at the Joint and Spine Clinic can be made by calling 312-757-4647 or visiting our website at https://mipainchicago.com/.
On June 10, Dr. Murtaza will lead a presentation at Lutheran Home to explain how the Spine and Joint's pain management physiatrists use evidence-based approaches to managing pain, enhancing mobility and improving your quality of life—all without the risks associated with narcotic medications. To RSVP and learn more, visit: https://lutheranlifecommunities.org/event/lutheran-home-spine-joint-relief-redefined/#FormBgAnchor
ABOUT METROPOLITAN INSTITUTE OF PAIN
Metropolitan Institute of Pain employs a fully integrated approach to your healthcare to ensure the precise evaluation, diagnosis and treatment of the cause of your pain. Our expert team of Board-Certified Physical Medicine & Rehabilitation and Interventional Pain Management Specialists will take the necessary time to effectively diagnose and explain the nonsurgical treatments available to you. https://mipainchicago.com/.
ABOUT LUTHERAN HOME
Lutheran Home is part of Lutheran Life Communities, a faith-based 501(c)(3) not-for-profit organization founded over 130 years ago that supports Arlington Heights with a full spectrum of care and services. Recognized on Newsweek's America's Best Nursing Homes 2025 list, they offer assisted living, memory care, skilled nursing, an adult day club, inpatient and outpatient rehab, home care services, move management services and Shepherd's Flock Child Care and Preschool and Jenny's Bistro, which is open to the public and serves gourmet food and beverages.
Lutheran Home invests in a full, robust continuum of care that can address early dementia and mild cognitive impairment with stage-form care, supportive services and residential solutions like MyTapestry memory support. The memory support programming extends through end of life with care provided by a care team trained in dementia. It's Grace-Filled living. https://lutheranlifecommunities.org/lutheranhome/
NEWS SOURCE: Lutheran Life Communities
Keywords: Illinois Business, Senior Living, Lutheran Home, Lutheran Life Communities, spinal center, Metropolitan Institute of Pain, ARLINGTON HEIGHTS, Ill.
This press release was issued on behalf of the news source (Lutheran Life Communities) who is solely responsibile for its accuracy, by Send2Press® Newswire. Information is believed accurate but not guaranteed. Story ID: S2P126513 APNF0325A
To view the original version, visit: https://www.send2press.com/wire/new-joint-and-spine-clinic-to-open-on-lutheran-home-campus-in-arlington-heights/
© 2025 Send2Press® Newswire, a press release distribution service, Calif., USA.
RIGHTS GRANTED FOR REPRODUCTION IN WHOLE OR IN PART BY ANY LEGITIMATE MEDIA OUTLET - SUCH AS NEWSPAPER, BROADCAST OR TRADE PERIODICAL. MAY NOT BE USED ON ANY NON-MEDIA WEBSITE PROMOTING PR OR MARKETING SERVICES OR CONTENT DEVELOPMENT.
Disclaimer: This press release content was not created by nor issued by the Associated Press (AP). Content below is unrelated to this news story.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
22 minutes ago
- Yahoo
Cboe Files for New Generic Listing Standards for Crypto ETPs
The Chicago Board Options Exchange filed for Generic Listing Standards for crypto exchange-traded products on Wednesday—a move that could make a big difference for fund issuers. If the filing is approved, any coin that has futures tracking it for at least six months on Coinbase's derivatives exchange would be approved, Bloomberg Senior ETF Analyst Eric Balchunas said via X. The filing is still subject to comment and review, but could be on a path to finality in less than 60 days, Greg Xethalis, general counsel at crypto investing firm Multicoin Capital, said in a post on X. He added that the New York Stock Exchange and Nasdaq exchange will likely follow in the footsteps of Cboe shortly. What the Generic Listing Standards Could Mean 'The new rule allows an issuer's shares to be listed on an exchange if the underlying commodity to which exposure is given has a contract on a Designated Contract Market for at least 6 months,' Xethalis said. It would also make the possibility of staking—a process in which crypto investors can earn rewards for their transactions—easier via a rule that would require a liquidity risk management program if less than 85% of the assets are available for immediate redemption, per the filing. Solana ETPs, which must be approved by Oct. 10, would qualify this fall under the Generic Listing Standards if they're approved by the agency, Xethalis said. The SEC Is Sitting on Crypto ETP Applications The crypto industry is eagerly awaiting approvals on crypto-related exchange-traded products. 'People have to be patient,' SEC Commissioner Hester Peirce recently said in an interview with Bloomberg's Trillions podcast. 'The SEC could choose to act directly on those ETP 19b-4s before the Oct. 10 Solana deadline and the slightly later XRP deadline, or could run these out under GLS,' Xethalis said. Balchunas said that the process of launching ETFs related to newer alt coins that don't have futures or meme coins would need to come from a different | © Copyright 2025 All rights reserved Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
22 minutes ago
- Yahoo
Eastman Chemical forecasts downbeat quarterly profit, to reduce inventory as tariffs bite
(Reuters) -Eastman Chemical projected a downbeat third-quarter profit on Thursday and announced plans to cut inventory amid soft demand and U.S. trade policy challenges, sending its shares down over 10% after the bell. Global chemical companies are under pressure to reassess strategies due to increasing production costs, lackluster demand and stringent environmental regulations in key markets. The industry is also bracing itself for the impact of U.S. President Donald Trump's sweeping tariffs on most imports, which have forced companies to contend with higher raw material costs and weakening demand. "As we have entered the second half of the year, we are encountering a global macroeconomic environment that remains challenging," CEO Mark Costa said. "Customer caution is intensifying due to a changing tariff landscape and weak underlying demand," Costa added. Eastman Chemical makes a wide range of chemicals used in manufacturing end-products across the construction, agricultural and automotive sectors. The impacts of the trade dispute and seasonality would result in a decline in volumes in the second half of the year, the company said, adding that it plans to reduce inventory by more than $200 million below current levels. The reduction of inventory is expected to negatively impact earnings by $75 million to $100 million for the rest of the year, with around $50 million of that impact expected in the current quarter. The Kingsport, Tennessee-based company said it expects an adjusted profit of $1.25 per share for the third quarter ending September 30, falling short of analysts' expectations of $1.91 per share, according to data compiled by LSEG.
Yahoo
22 minutes ago
- Yahoo
Workiva's (NYSE:WK) Q2: Strong Sales, Stock Soars
Financial and compliance reporting software company Workiva (NYSE:WK) beat Wall Street's revenue expectations in Q2 CY2025, with sales up 21.2% year on year to $215.2 million. The company expects next quarter's revenue to be around $219 million, close to analysts' estimates. Its non-GAAP profit of $0.19 per share was significantly above analysts' consensus estimates. Is now the time to buy Workiva? Find out in our full research report. Workiva (WK) Q2 CY2025 Highlights: Revenue: $215.2 million vs analyst estimates of $208.9 million (21.2% year-on-year growth, 3% beat) Adjusted EPS: $0.19 vs analyst estimates of $0.05 (significant beat) Adjusted Operating Income: $8.23 million vs analyst estimates of $549,430 (3.8% margin, significant beat) The company slightly lifted its revenue guidance for the full year to $871.5 million at the midpoint from $866 million Management raised its full-year Adjusted EPS guidance to $1.35 at the midpoint, a 27.5% increase Operating Margin: -10.3%, up from -13% in the same quarter last year Free Cash Flow was $49.32 million, up from -$8.12 million in the previous quarter Customers: 6,467, up from 6,385 in the previous quarter Net Revenue Retention Rate: 114%, up from 110% in the previous quarter Billings: $230.6 million at quarter end, up 20.6% year on year Market Capitalization: $3.71 billion Company Overview Founded in 2010, Workiva (NYSE:WK) offers software as a service product that makes financial and compliance reporting easier, especially for publicly traded corporations. Revenue Growth A company's long-term performance is an indicator of its overall quality. Any business can experience short-term success, but top-performing ones enjoy sustained growth for years. Over the last three years, Workiva grew its sales at a 17.7% compounded annual growth rate. Although this growth is acceptable on an absolute basis, it fell slightly short of our standards for the software sector, which enjoys a number of secular tailwinds. Luckily, there are other things to like about Workiva. This quarter, Workiva reported robust year-on-year revenue growth of 21.2%, and its $215.2 million of revenue topped Wall Street estimates by 3%. Company management is currently guiding for a 18% year-on-year increase in sales next quarter. Looking further ahead, sell-side analysts expect revenue to grow 15.6% over the next 12 months, a slight deceleration versus the last three years. Despite the slowdown, this projection is healthy and suggests the market is baking in success for its products and services. Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link. Billings Billings is a non-GAAP metric that is often called 'cash revenue' because it shows how much money the company has collected from customers in a certain period. This is different from revenue, which must be recognized in pieces over the length of a contract. Workiva's billings punched in at $230.6 million in Q2, and over the last four quarters, its growth was impressive as it averaged 22.3% year-on-year increases. This alternate topline metric grew faster than total sales, meaning the company collects cash upfront and then recognizes the revenue over the length of its contracts - a boost for its liquidity and future revenue prospects. Customer Retention One of the best parts about the software-as-a-service business model (and a reason why they trade at high valuation multiples) is that customers typically spend more on a company's products and services over time. Workiva's net revenue retention rate, a key performance metric measuring how much money existing customers from a year ago are spending today, was 112% in Q2. This means Workiva would've grown its revenue by 11.8% even if it didn't win any new customers over the last 12 months. Trending up over the last year, Workiva has a good net retention rate, proving that customers are satisfied with its software and getting more value from it over time, which is always great to see. Key Takeaways from Workiva's Q2 Results We were impressed by how significantly Workiva blew past analysts' billings expectations this quarter. We were also glad its EPS guidance for next quarter trumped Wall Street's estimates. Zooming out, we think this was a good print with some key areas of upside. The stock traded up 5.9% to $67.60 immediately after reporting. Sure, Workiva had a solid quarter, but if we look at the bigger picture, is this stock a buy? We think that the latest quarter is just one piece of the longer-term business quality puzzle. Quality, when combined with valuation, can help determine if the stock is a buy. We cover that in our actionable full research report which you can read here, it's free. Sign in to access your portfolio
